Presentation Information
[AL22]Invention of a SARS-CoV-2 RNA vaccine using DS-LNP-mRNA technology
○Nao Jonai1, Natsuki Tanaka2, Takako Niwa3, Takashi Suzuki4 (1. Vaccine Research Laboratories, Daiichi Sankyo Co., LTD., 2. R&D Portfolio Planning Department, Daiichi Sankyo Co., LTD., 3. Modality Research Laboratories I, Daiichi Sankyo Co., LTD., 4. Bioprocess Technology Research Laboratories II, Daiichi Sankyo Co., LTD.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
